In the fast-evolving landscape of generic pharmaceuticals, Oxcarbazepine stands out as a cornerstone anticonvulsant, widely prescribed for epilepsy and bipolar disorder. With global epilepsy prevalence affecting approximately 50 million people and the continued expiration of brand patents, the market for this active pharmaceutical ingredient (API) remains robust . However, for manufacturers and exporters, the challenge isn’t just producing high-quality Oxcarbazepine—it’s identifying and connecting with verified, high-volume global buyers. This guide moves beyond a simple list to provide a strategic framework for understanding the Oxcarbazepine buyer ecosystem, recent market shifts, and how to navigate procurement channels effectively. Understanding the Oxcarbazepine Market Landscape Before diving into buyer identification, it’s crucial to understand who is buying and why. The Oxcarbazepine…